Medtronic Inc. (NYSE:MDT) is sending its Contour 3D annuloplasty ring out into the world.
The Fridley, Minn.-based medical device giant’s latest device is designed to treat tricuspid valve disease, in which the valve between the heart’s right atrium and the right ventricle doesn’t function properly. The ring slips over the three-leaflet valve to restore its function.